PRF Technologies Ltd
Research PRF Technologies Ltd (PRFX) on Bullrun: market cap USD 779.18K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPRFX
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 779.18K
- Financial periodFY2025
- RevenueUSD 17.00K
- Net income-USD 5.02M
- Free cash flow-USD 3.96M
- Gross margin-311.8%
Valuation Snapshot
latest market cap is USD 779.18K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 17.00K | -USD 5.02M | -USD 3.96M | -311.8% | -7.47 | USD 3.13M | USD 21.00K | USD 8.54M |
| FY2024 | USD 0 | -USD 14.59M | -USD 12.63M | n/a | -105.52 | USD 4.26M | USD 59.00K | USD 1.82M |
| FY2023 | USD 0 | -USD 9.34M | -USD 6.69M | n/a | -122.94 | USD 8.03M | USD 86.00K | USD 7.24M |
| FY2022 | n/a | -USD 8.79M | -USD 6.47M | n/a | -63.46 | USD 4.10M | n/a | USD 11.02M |
| FY2021 | n/a | -USD 7.25M | -USD 6.60M | n/a | -7.25 | USD 16.54M | n/a | USD 18.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 779.18K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.51M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.94M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.07M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.10M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.47M | n/a | n/a | n/a |
About PRF Technologies Ltd
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PRF Technologies Ltd's market cap?
PRF Technologies Ltd's market capitalization is USD 779.18K.
What does PRF Technologies Ltd do?
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd.